Advertisment

Astellas launches cardiac imaging test app

author-image
CIOL Bureau
Updated On
New Update

PHILADELPHIA, USA:  Today Astellas Pharma US, Inc. ("Astellas") announced the Launch of the Appropriate Use Criteria (AUC) for Cardiac Radionuclide Imaging application (app) for smartphones.

Advertisment

The app is designed to give physicians access to published criteria used to assess the need for a patient to have cardiac radionuclide imaging (RNI). The app will be available for free download on the iPhone, BlackBerry and Android platforms.

The app guides physicians step-by-step through the criteria to evaluate patient history, clinical factors, and other important information to receive an instant appropriate use score for RNI. By entering information, physicians will receive a rating on a scale of 1-9 suggesting if the patient indication is appropriate (7-9), uncertain (4-6), or inappropriate (1-3) for RNI. Ratings can be viewed either by indication/category or patient algorithm.

According to the annual "Taking the Pulse" study of physicians and healthcare technology released in April 2010, 72 percent of physicians use smartphones personally and professionally, with that number expected to jump to 81 percent in 2012.

Advertisment

"Astellas recognizes physicians are increasingly using smartphones and apps in the healthcare setting to access information," said Robert C. Hendel, Chair of the Cardiac Radionuclide Imaging Writing Group that developed the 2009 AUC for RNI.

"We partnered with them to develop this accurate, timely, assessment tool for use on smartphones and hope this app will promote awareness and use of the AUC for RNI published in 2009," Dr. Hendel added.



tech-news